Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2019-06-26 23:56 2019-06-24 PRVL N/A Thompson Peter A. Director, 10% owner Other BUY $17.00 882,352 $14,999,984 13,822,463 +6.8%
2019-06-26 23:55 2019-06-24 PRVL N/A GORDON CARL L Director, 10% owner Other BUY $17.00 882,352 $14,999,984 13,822,463 +6.8%
2019-06-26 15:52 2019-06-25 VTVT vTv Therapeutics Inc. PERELMAN RONALD O 10% owner Pharmaceutical Preparations BUY $1.65 1,212,121 $2,000,000 19,064,472 +6.8%
2019-06-26 17:46 2019-06-24 GNCA N/A GLAXOSMITHKLINE PLC 10% owner Other BUY $3.50 1,857,142 $6,499,997 3,365,884 +123.1%
2019-06-26 23:54 2019-06-24 PRVL N/A ORBIMED ADVISORS LLC Director, 10% owner Other BUY $17.00 882,352 $14,999,984 13,822,463 +6.8%
2019-06-26 23:51 2019-06-24 ELOX N/A Nussbaum Ran Director Other BUY $9.00 200,000 $1,800,000 24,000 +100.0%
2019-06-26 23:48 2019-06-24 ELOX N/A Kariv Tomer Director Other BUY $9.00 200,000 $1,800,000 24,000 +100.0%
2019-06-26 23:44 2019-06-24 ELOX N/A Pontifax Management 4 G.P. (2015) Ltd. 10% owner Other BUY $9.00 200,000 $1,800,000 24,000 +100.0%
2019-06-26 01:05 2019-06-24 AKRO Akero Therapeutics, Inc. Royston Aaron Director Pharmaceutical Preparations BUY $16.00 250,000 $4,000,000 250,000 +100.0%
2019-06-26 01:06 2019-06-24 AKRO Akero Therapeutics, Inc. Atlas Venture Fund XI, L.P. 10% owner Pharmaceutical Preparations BUY $16.00 270,000 $4,320,000 505,099 +114.8%
2019-06-26 01:05 2019-06-24 AKRO Akero Therapeutics, Inc. Versant Venture Capital VI, L.P. 10% owner Pharmaceutical Preparations BUY $16.00 400,000 $6,400,000 4,104,858 +10.8%
2019-06-26 01:04 2019-06-24 AKRO Akero Therapeutics, Inc. Apple Tree Partners IV, L.P. 10% owner Pharmaceutical Preparations BUY $16.00 900,000 $14,400,000 5,415,203 +19.9%
2019-06-26 01:06 2019-06-24 AKRO Akero Therapeutics, Inc. Bitterman Kevin Director Pharmaceutical Preparations BUY $16.00 270,000 $4,320,000 505,099 +114.8%
2019-06-25 23:52 2019-06-24 GNCA N/A Sonsini Peter W. 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:50 2019-06-24 GNCA N/A Makhzoumi Mohamad 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:50 2019-06-24 GNCA N/A Florence Anthony A. Jr. 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:50 2019-06-24 GNCA N/A Chang Carmen 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:49 2019-06-24 GNCA N/A Behbahani Ali Director, 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:48 2019-06-24 GNCA N/A New Enterprise Associates 16, L.P. 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-26 01:05 2019-06-24 AKRO Akero Therapeutics, Inc. Harrison Seth Loring Director, 10% owner Pharmaceutical Preparations BUY $16.00 900,000 $14,400,000 5,415,203 +19.9%
2019-06-25 23:30 2019-06-21 MGM MGM Resorts International Meister Keith A. Director Hotels & Motels BUY $27.81 380,651 $10,587,731 20,354,560 +1.9%
2019-06-25 16:20 2019-06-24 AKRO Akero Therapeutics, Inc. venBio Global Strategic Fund II L.P. 10% owner Pharmaceutical Preparations BUY $16.00 250,000 $4,000,000 250,000 +100.0%
2019-06-25 23:49 2019-06-24 GNCA N/A BASKETT FOREST 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:52 2019-06-24 GNCA N/A SANDELL SCOTT D 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:51 2019-06-24 GNCA N/A MAKOWER JOSHUA 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 23:51 2019-06-24 GNCA N/A MOTT DAVID M 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-26 03:18 2019-06-24 RUN Sunrun Inc. TIGER GLOBAL MANAGEMENT LLC 10% owner Miscellaneous Electrical Machinery, Equipment & Supplies BUY $18.60 833,677 $15,504,058 12,363,738 +7.2%
2019-06-26 00:24 2019-06-21 ETM N/A FIELD JOSEPH M Director, Officer, 10% owner - Chairman Emeritus Other BUY $5.96 200,000 $1,192,040 12,196,110 +1.7%
2019-06-25 23:48 2019-06-24 GNCA N/A BARRIS PETER J 10% owner Other BUY $3.50 2,857,142 $9,999,997 7,225,676 +65.4%
2019-06-25 03:01 2019-06-24 PSNL Personalis, Inc. LUDLUM KEN Director Services-Medical Laboratories BUY $17.00 70,000 $1,190,000 70,000 +100.0%
2019-06-24 13:09 2019-06-20 SGMS Light & Wonder, Inc. PERELMAN RONALD O Director, 10% owner Services-Computer Integrated Systems Design BUY $20.21 75,000 $1,515,750 36,443,768 +0.2%
2019-06-25 01:54 2019-06-20 RUN Sunrun Inc. TIGER GLOBAL MANAGEMENT LLC 10% owner Miscellaneous Electrical Machinery, Equipment & Supplies BUY $18.62 1,016,343 $18,926,339 11,951,069 +9.3%
2019-06-24 21:12 2019-06-20 DRRX N/A First Eagle Investment Management, LLC 10% owner Other BUY $0.52 4,000,000 $2,080,000 26,476,546 +17.8%
2019-06-25 03:01 2019-06-20 CSU SONIDA SENIOR LIVING, INC. Levinson Sam 10% owner Services-Nursing & Personal Care Facilities BUY $4.28 242,177 $1,036,518 3,715,921 +7.0%
2019-06-22 03:50 2019-06-18 NAVB N/A Scott John K Jr. 10% owner Other BUY $0.75 4,000,000 $3,000,000 5,113,078 +359.4%
2019-06-21 23:59 2019-06-21 STOK Stoke Therapeutics, Inc. Apple Tree Partners IV, L.P. 10% owner Pharmaceutical Preparations BUY $18.00 1,388,889 $25,000,002 16,786,713 +9.0%
2019-06-22 01:13 2018-12-18 ASDN N/A Bent Bruce Director, Officer, 10% owner - CEO, CFO Other BUY $97,658.75 285,000 $27,832,745,004 54,556,937 +0.5%
2019-06-22 00:47 2018-09-27 ASDN N/A Bent Bruce Director, Officer, 10% owner - CEO, CFO Other BUY $36,729.19 305,803 $11,231,896,398 54,855,137 +0.6%
2019-06-21 23:48 2018-09-04 ASDN N/A Bent Bruce Director, Officer, 10% owner - CEO, CFO Other BUY $44,901.49 172,651 $7,752,286,736 54,637,798 +0.3%
2019-06-21 22:41 2018-07-26 ASDN N/A Bent Bruce Director, Officer, 10% owner - CEO, CFO Other BUY $8,045.22 36,198 $291,220,740 54,527,524 +0.1%
2019-06-22 00:01 2019-06-21 STOK Stoke Therapeutics, Inc. Harrison Seth Loring Director, 10% owner Pharmaceutical Preparations BUY $18.00 1,388,889 $25,000,002 16,786,713 +9.0%
2019-06-22 02:33 2019-06-03 FSLY Fastly, Inc. Abdiel Capital Management, LLC 10% owner Services-Prepackaged Software BUY $19.92 250,000 $4,980,000 2,100,000 +13.5%
2019-06-21 23:27 2019-06-19 RUN Sunrun Inc. TIGER GLOBAL MANAGEMENT LLC 10% owner Miscellaneous Electrical Machinery, Equipment & Supplies BUY $17.82 170,696 $3,041,803 19,004,096 +0.9%
2019-06-20 16:50 2019-06-19 STOK Stoke Therapeutics, Inc. RTW INVESTMENTS, LP 10% owner Pharmaceutical Preparations BUY $18.00 555,556 $10,000,008 3,355,466 +19.8%
2019-06-21 00:28 2019-06-18 MGM MGM Resorts International Meister Keith A. Director Hotels & Motels BUY $27.84 338,374 $9,421,280 19,973,909 +1.7%
2019-06-20 23:17 2019-06-18 MCRB Seres Therapeutics, Inc. AFEYAN NOUBAR Director, 10% owner Pharmaceutical Preparations BUY $2.25 8,888,888 $19,999,998 4,444,444 +100.0%
2019-06-20 16:00 2019-06-19 IMMR IMMERSION CORP Singer Eric 10% owner Computer Peripheral Equipment, NEC BUY $7.57 175,000 $1,324,995 1,550,498 +12.7%
2019-06-20 00:06 2019-06-17 CODI Compass Diversified Holdings SABO ELIAS Other Household Furniture BUY $18.99 55,000 $1,044,423 55,000 +100.0%
2019-06-20 01:33 2019-06-19 SGMS Light & Wonder, Inc. PERELMAN RONALD O Director, 10% owner Services-Computer Integrated Systems Design BUY $20.29 120,000 $2,434,800 36,368,768 +0.3%
2019-06-20 03:00 2019-06-17 ATNX N/A PERCEPTIVE ADVISORS LLC 10% owner Other BUY $17.94 130,000 $2,332,200 9,726,022 +1.4%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.